Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 277

1.

The neuronal cytoskeleton as a potential therapeutical target in neurodegenerative diseases and schizophrenia.

Benitez-King G, Ramírez-Rodríguez G, Ortíz L, Meza I.

Curr Drug Targets CNS Neurol Disord. 2004 Dec;3(6):515-33. Review.

PMID:
15581421
2.

Melatonin as a cytoskeletal modulator: implications for cell physiology and disease.

Benítez-King G.

J Pineal Res. 2006 Jan;40(1):1-9. Review.

PMID:
16313492
3.

Transgenic zebrafish model of neurodegeneration.

Tomasiewicz HG, Flaherty DB, Soria JP, Wood JG.

J Neurosci Res. 2002 Dec 15;70(6):734-45.

PMID:
12444595
4.

Tau phosphorylation in neuronal cell function and dysfunction.

Johnson GV, Stoothoff WH.

J Cell Sci. 2004 Nov 15;117(Pt 24):5721-9. Review.

5.
6.

Aluminum-induced neuropathology: transient changes in microtubule-associated proteins.

Muma NA, Singer SM.

Neurotoxicol Teratol. 1996 Nov-Dec;18(6):679-90.

PMID:
8947945
7.

Neurodegeneration and plasticity.

Arendt T.

Int J Dev Neurosci. 2004 Nov;22(7):507-14. Review.

PMID:
15465280
8.

Phosphorylated serine 199 of microtubule-associated protein tau is a neuronal epitope abundantly expressed in youth and an early marker of tau pathology.

Maurage CA, Sergeant N, Ruchoux MM, Hauw JJ, Delacourte A.

Acta Neuropathol. 2003 Feb;105(2):89-97. Epub 2002 Sep 7.

PMID:
12536218
9.

Interactions of amyloidogenic proteins.

Giasson BI, Lee VM, Trojanowski JQ.

Neuromolecular Med. 2003;4(1-2):49-58. Review.

PMID:
14528052
10.

Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.

Padmanabhan J, Levy M, Dickson DW, Potter H.

Brain. 2006 Nov;129(Pt 11):3020-34. Epub 2006 Sep 20.

PMID:
16987932
11.

Tau and axonopathy in neurodegenerative disorders.

Higuchi M, Lee VM, Trojanowski JQ.

Neuromolecular Med. 2002;2(2):131-50. Review.

PMID:
12428808
12.
13.

Linking amyloid-β and tau: amyloid-β induced synaptic dysfunction via local wreckage of the neuronal cytoskeleton.

Zempel H, Mandelkow EM.

Neurodegener Dis. 2012;10(1-4):64-72. doi: 10.1159/000332816. Epub 2011 Dec 7.

PMID:
22156588
14.

The cytoskeleton in oligodendrocytes. Microtubule dynamics in health and disease.

Richter-Landsberg C.

J Mol Neurosci. 2008 May;35(1):55-63. Epub 2007 Dec 4. Review.

PMID:
18058074
15.

How do neurons die in neurodegenerative diseases?

Kanazawa I.

Trends Mol Med. 2001 Aug;7(8):339-44.

PMID:
11516993
16.

Phosphorylation-dephosphorylation imbalance of cytoskeletal associated proteins in neurodegenerative diseases.

Benítez-King G, Ortiz-López L, Morales-Mulia S, Jiménez-Rubio G, Ramírez-Rodríguez G, Meza I.

Recent Pat CNS Drug Discov. 2006 Jun;1(2):219-30.

PMID:
18221204
17.

Phosphorylation of neuronal cytoskeletal proteins in Alzheimer's disease and Lewy body dementias.

Trojanowski JQ, Lee VM.

Ann N Y Acad Sci. 1994 Dec 15;747:92-109. Review. No abstract available.

PMID:
7847694
18.

Probing modifications of the neuronal cytoskeleton.

Doering LC.

Mol Neurobiol. 1993 Fall-Winter;7(3-4):265-91. Review.

PMID:
8179841
19.

Neurofibrillary degeneration in Alzheimer's disease: from molecular mechanisms to identification of drug targets.

Pei JJ, Sjögren M, Winblad B.

Curr Opin Psychiatry. 2008 Nov;21(6):555-61. doi: 10.1097/YCO.0b013e328314b78b. Review.

PMID:
18852562
20.

6-hydroxydopamine-induced lesions of dopaminergic neurons alter the function of postsynaptic cholinergic neurons without changing cytoskeletal proteins.

Muma NA, Lee JM, Gorman L, Heidenreich BA, Mitrovic I, Napier TC.

Exp Neurol. 2001 Mar;168(1):135-43.

PMID:
11170728

Supplemental Content

Support Center